Our current study is centered on investigating the role, significance, therapeutic possibilities, and prognostic value of PANoptosis-associated genes (PRGs) and pathways in molding the tumor microenvironment, impacting immune responses, and influencing patient outcomes in the context of BC. Here, GART is linked to breast cancer.